XML 99 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Voting
Additional Paid In Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Retained Earnings
Beginning balance (in shares) at Mar. 31, 2018   117,744,913     37,474,890  
Beginning balance at Mar. 31, 2018 $ 2,068,782 $ 117 $ 2,665,120 $ 2,895 $ (995,843) $ 396,493
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (92,535)         (92,535)
Unrealized net investment gains 35     35    
Unrealized net losses on derivative financial instruments (219)     (219)    
Cumulative translation adjustments (3,319)     (3,319)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,369,122        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 40,423   40,423      
Issuance of common stock under employee stock purchase plan (in shares)   302,994        
Issuance of common stock under employee stock purchase plan 7,575   7,575      
Repurchase of treasury stock (in shares)         4,110,353  
Repurchase of treasury stock (11,416)   96,783   $ (108,199)  
Ending balance (in shares) at Dec. 31, 2018   119,417,029     41,585,243  
Ending balance at Dec. 31, 2018 2,043,477 $ 119 2,809,901 (608) $ (1,104,042) 338,107
Beginning balance (in shares) at Sep. 30, 2018   119,231,287     41,526,563  
Beginning balance at Sep. 30, 2018 2,036,598 $ 119 2,796,695 555 $ (1,102,481) 341,710
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (3,603)         (3,603)
Unrealized net investment gains 12     12    
Unrealized net losses on derivative financial instruments (5)     (5)    
Cumulative translation adjustments (1,170)     (1,170)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   185,742        
Issuance of common stock pursuant to vesting of restricted stock units 0 $ 0        
Stock-based compensation expense for restricted stock units granted to employees 13,206   13,206      
Repurchase of treasury stock (in shares)         58,680  
Repurchase of treasury stock (1,561)       $ (1,561)  
Ending balance (in shares) at Dec. 31, 2018   119,417,029     41,585,243  
Ending balance at Dec. 31, 2018 2,043,477 $ 119 2,809,901 (608) $ (1,104,042) 338,107
Beginning balance (in shares) at Mar. 31, 2019   119,760,132     42,149,771  
Beginning balance at Mar. 31, 2019 2,065,433 $ 120 2,828,922 (2,639) $ (1,119,063) 358,093
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (10,090)         (10,090)
Unrealized net investment gains 40     40    
Unrealized net losses on derivative financial instruments 43     43    
Cumulative translation adjustments (789)     (789)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,621,350        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 38,187   38,187      
Issuance of common stock under employee stock purchase plan (in shares)   297,635        
Issuance of common stock under employee stock purchase plan 6,593   6,593      
Repurchase of treasury stock (in shares)         5,674,125  
Repurchase of treasury stock (136,612)       $ (136,612)  
Ending balance (in shares) at Dec. 31, 2019   121,679,117     47,823,896  
Ending balance at Dec. 31, 2019 1,962,807 $ 122 2,873,702 (3,345) $ (1,255,675) 348,003
Beginning balance (in shares) at Sep. 30, 2019   121,648,747     46,810,700  
Beginning balance at Sep. 30, 2019 1,940,264 $ 122 2,863,003 (3,699) $ (1,230,440) 311,278
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 36,725         36,725
Unrealized net investment gains 3     3    
Unrealized net losses on derivative financial instruments 54     54    
Cumulative translation adjustments 297     297    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   30,370        
Issuance of common stock pursuant to vesting of restricted stock units 0 $ 0        
Stock-based compensation expense for restricted stock units granted to employees 10,699   10,699      
Repurchase of treasury stock (in shares)         1,013,196  
Repurchase of treasury stock (25,235)       $ (25,235)  
Ending balance (in shares) at Dec. 31, 2019   121,679,117     47,823,896  
Ending balance at Dec. 31, 2019 $ 1,962,807 $ 122 $ 2,873,702 $ (3,345) $ (1,255,675) $ 348,003